StrongBox Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,140
Closed -$476K 90
2024
Q1
$476K Sell
17,140
-11,242
-40% -$312K 0.25% 53
2023
Q4
$817K Sell
28,382
-16,546
-37% -$500K 0.48% 49
2023
Q3
$1.49M Buy
44,928
+7,321
+19% +$259K 0.95% 39
2023
Q2
$1.38M Buy
37,607
+4,272
+13% +$166K 0.87% 37
2023
Q1
$1.36M Buy
+33,335
New +$1.44M 0.91% 38

Other funds holding PFE

StrongBox Wealth's PFE Position: Q2 2024 in Review

StrongBox Wealth sold out of Pfizer (PFE) in Q2 2024, closing a stake of 17,140 shares — an estimated $476K sold.

StrongBox Wealth first reported a position in PFE in Q1 2023 and held it in 5 quarters. The position peaked at $1.49M in Q3 2023. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • StrongBox Wealth reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • StrongBox Wealth sold 17,140 Pfizer shares in Q2 2024, an estimated $476K.
  • StrongBox Wealth first reported a position in Pfizer in Q1 2023 and held it in 5 quarters.
  • StrongBox Wealth's Pfizer position peaked at $1.49M in Q3 2023.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on StrongBox Wealth's 13F filing for Q2 2024, filed 12 Aug 2024.